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ABSTRACT

The native heart valve will open and close an astonishing 3 billion times in the
average lifetime, implicating immense biomechanical ramifications that necessitate nearflawless structure and functional behavior [1,2]. Deviations from this idyllic function are
a result of heart valve disease (HVD) which affects millions of individuals worldwide
and results in over 300,000 heart valve replacements worldwide every year [3,4].
Glutaraldehyde (GLUT) cross-linked porcine aortic heart valves, a common type of
bioprosthetic heart valve (BHV), are used frequently in these valve replacement
surgeries. The native aortic valve leaflets entail a tri-composite design of type I collagen,
elastin and glycosaminoglycans (GAGs); each of which are important structural and
functional biomechanical components.
Our group has previously characterized the loss of GAGs from BHVs due to the
inability of GLUT-crosslinking to stabilize these structures during in-vitro storage,
fatigue, enzymatic degradation and in-vivo implantation [5-8]. Consequences of GAG
loss include, but are not limited to, decreased hydration, loss of tissue compliancy, altered
leaflet morphology and the potential compromise of collagen organization and
mechanical integrity [5,9] .
This study explicitly examines the ability of neomycin to enhance glutaraldehyde
crosslinking (NG) and stabilize GAGs. Evidence for enhanced crosslinking using
neomycin was supported by increased resistance to enzymatic collagen and elastin
degradation compared to that of standard GLUT-crosslinking and by a small but
significant increase in collagen denaturation temperatures as measured using differential
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scanning calorimetry. NG-crosslinked leaflets also exhibited a slightly diminished
hydration capacity compared to GLUT leaflets, indicating potentially adverse
biomechanical effects. However, biaxial tensile testing revealed no significant alterations
in compliancy during NG versus GLUT-crosslinking. NG-crosslinked leaflets subjected
to in-vitro storage, accelerated cyclic fatigue and enzyme-mediated GAG degradation
revealed improved GAG stabilization versus standard GLUT-crosslinked leaflets, which
sustained substantial decreases in GAG content. Lastly, ultrastructural analysis using
transmission electron microscopy qualitatively assessed preservation of GAGs in NGcrosslinked leaflets and yielded insight into their morphological preservation utilizing NG
crosslinking. Thus, we hypothesized that preservation of the GAG matrix using NG
crosslinking may help maintain biomechanical function and ultimately improve tissue
durability.
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CHAPTER 1: INTRODUCTION
1.1

1.1.1

The Heart Valves

Gross Anatomy and Physiology

The heart lies at the center of the cardiovascular system and provides the driving
force that circulates blood throughout our body. This system is comprised of two circuits,
the first being a relatively low resistance route that travels to the lungs known as the
pulmonary circuit. The systemic circuit receives oxygenated blood returning from the
pulmonary circuit and transports it to the rest of the body [10]. To ensure that the heart
maintains efficient and unidirectional blood-flow, a total of four heart valves are
necessary to prevent retrograde blood flow (Figure 1). These connective tissues are
composed of two or three leaflets, also called “cusps” due to their shapes which open and
close during the cardiac cycle.
The semi-lunar valves, located between the ventricles and the emerging arteries in
both circuits, consist of the pulmonary and aortic valves (AV). These valves prohibit the
retrograde flow of blood into the ventricles during diastole and because of their
anatomical location at the bottom of large arteries, form near-perfect circular perimeters
with similar size leaflets [11]. During closure, leaflets associate via tight inter-leaflet
junctions termed coaptation, providing a strong seal which prevents retrograde blood
flow [1].
The atrio-ventricular valves (the tricuspid and mitral valves) are located between
the atria and the ventricles. They are structurally complex, as they are not formed at the
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base of a circular vessel, but rather emerge from the complex and dynamic cardiac
muscle tissue within the heart. The atrio-ventricular leaflets are tapered to the ventricles
by chord-like structures called chordae tendinae, which serve as anchors to prevent the
prolapse of the valve into the atria and the successive retrograde flow that would arise
[1].
The valves located in the left side of the heart (the aortic and mitral valves) fulfill
a more demanding role in delivering blood to the systemic circuit exemplified by the
notably thick and muscular left ventricle that provides this driving force. [10]. Pressure
gradients in the pulmonary circuit reach ~10 mm Hg, but in the systemic circuit are an
average of ~80 mm Hg during diastole and ~120 mm Hg during systole [10]. These
pressure gradients must be maintained by the native heart valves over millions of cycles
nd hold important implications for heart valve function and durability.

3

Figure 1. (A) Cross-section of the heart and superficial view of the valves [12];
(B) Leaflet anatomy (radial and circumferential directions) [11].
1.1.2

The Native Aortic Valve

The complex structural design of the heart valve is critically refined to fulfill the
functional needs of the tissue as highlighted by their strict conservation throughout the
selective pressures of evolution [13].

The aortic valve leaflets themselves are

characterized by a smooth belly region, coaptation regions and a thicker nodular region
where all three leaflets of the tricuspid valves convene during closure (Figure 1).
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Regardless of gross morphological differences, all heart valve leaflets are composed of a
similar tri-composite arrangement of type I collagen, elastin and glycosaminoglycans
(GAGs), each of which play important structural and functional roles within the tissue
[1,3,14].
The transvalvular pressures induced during closure reveal dissimilar axial
deformations behaviors in the circumferential and radial axes of the leaflets (see Figure
1B for leaflet axis definition). This leaflet behavior is reflective of the orthogonally
aligned fiber constituents, elastin and collagen, whereby large deformations are induced
radially but are minimal in the circumferential direction. The native aortic valve (AV)
will be described here, as it is the most frequently diseased, widely transplanted and
extensively studied heart valve and suffices in illustrating the functional significance of
these layers in all the other heart valves [1,14,15].
The composition of the AV include of valvular interstitial cells, endothelial cells
and

the

extra

cellular

matrix

(ECM)

components

collagen,

elastin

and

glycosaminoglycans (GAGs). Valvular interstitial cells (VICs) have features reminiscent
of both smooth muscle cells and fibroblasts and are also known as myo-fibroblasts.
Collectively, these two cell types play a critical role in remodeling and rebuilding the
local fibrous matrix [14]. The endothelial layer plays a pivotal role in preventing collagen
exposure to blood, protecting internal structures from shear and providing a smooth
ventricular surface for optimal blood flow during systole [13]. Collectively, the cells and
three ECM components are arranged in differing concentrations throughout the three
layers of the native AV: the fibrosa, spongiosa and ventricularis (Figure 2).
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Figure 2. (A) Schematic of the native aortic valve layers[14]; (B) Histological analysis
using Movat’s Pentachrome Stain [16,17].
1.1.2.1 Fibrosa
The fibrosa is the most functionally critical of the leaflets layers and houses an
abundant supply of tensile load-bearing collagen fibers and collagen associated GAG’s.
The collagen is organized in sheets and bundles in the circumferential direction,
providing crucial strength and stiffness during closure to maintain unwaveringcrosslinked leaflet coaptation (preventing prolapse and regurgitation) [13]. The
morphological features of the fibrosa that facilitate this function include corrugations
during the relaxed state, which appear as circumferential aligned surface ripples around 1
mm in periodicity that flatten during closure (Figure 3). Lack of these corrugations might
otherwise preclude the fibrosa to radial tearing and fenestrations (Figure 12) [2,13,18].
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Furthermore, collagen bundles are microscopically crimped in a periodicity approaching
20 µm during the fully relaxed state and are straightened out during tensile loading,
permitting circumferential extensibility of the fibrosa that sanctions proper coaptation
(Figure 3) [2,13,14,19].

Figure 3. (A) Collagen crimping [9]; (B) Leaflet corrugations [9,11].
1.1.2.2 Ventricularis
The fibrosa is tightly associated with the ventricularis, a layer that faces the
ventricles of the heart and the corresponding flow of blood during ventricular contraction.
The smooth lining of endothelial cells helps minimize the surface resistances to systolic
flow, which ameliorates the transfer of shear stresses to the other tissue layers [3]. The
ventricularis contains collagen and a substantial amount of elastin fibers that align in the
radial direction during closure. The layer itself is highly compliant and is able to undergo
a much larger degree of strain in the radial direction than the fibrosa in the
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[1]. This radial compliancy highlights its functional role in
circumferential direction [1]
allowing radial extensibility to facilitate valvular coaptation and closure during diastole.
Furthermore, the recoil
coil of elastin encourages the leaflet
leafletss to return to a relaxed state
during systole [14].. Thus, the morphological corrugations and collagen crimps exhibited
by the fibrosa
osa during systole are not just passively induced by flowing blood, but are
formed and maintained by the assistance of elastin fi
fiber
ber recoil in the ventricularis
(Figure 4) [13,14]. During
uring the “unloaded state” of systole when the valves are open, the
fibrosa is preloaded under compression by the ventricularis [14,20].. This is important and
helps maintain minimal resistance to blood flow by prompt escape of leaflets from the
central aortic conduit during the transition to systole. Furthermore, the preload helps
stabilize their shape, preventi
preventing leaflet flailing, drag and turbulent flow that would
otherwise compromise proper heart pumping efficiency.

Figure 4. Behavior of collagen and elastin
lastin fibers during systole and diastole [14].
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1.1.2.3 Spongiosa
During closure and pressurization, differential movements of peripheral layers are
created due to the dissimilar deformations of the ventricularis relative to the fibrosa,
resulting in shear, bending, tensile and compressive stresses (Figure 5). Furthermore,
flexure between phases of opening and closure result in additional contrary planar motion
and bending forces, necessitating the presence of a functional buffering zone between the
two layers [2,5,14].

Compression

Fibrosa
Spongiosa
Ventricularis

Applied
Bending
Force

Shear
Tension

Figure 5. Functionally induced forces on valvular tissues; shear, bending, tension and
compression [5].

This is met by the central spongiosa, which connects the ventricular and
spongiosa together via its gel-like matrix of loosely arranged collagen and GAGs
[1,2,14]. Its relatively high compliance attenuates potentially damaging shear stresses
created by the differential movement of peripheral layers during valve function [20-25].
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Furthermore, the spongiosa also acts like a lubricant to permit the dynamic movement of
structural fibers with minimal friction, further mitigating damaging behaviors [3,5]. Its
compressive resistant behavior is crucial to sustaining the morphological thickness of the
valves, which is important for deterrence of internal delamination, valvular buckling,
structural damage and eventual valve failure [9,26]. The role in compression resistance is
further posited to absorb shock of valvular closure during diastole [2,17,22,27]. All of
these functional roles of the spongiosa are facilitated by the abundant supply of GAGs
which absorb large amounts of water, providing the hydration necessary to maintain a
lubricated, compression-resistant and compliant buffering layer (Table 1) [5,16,27,28].
Table 1. Functional Roles of the Spongiosa

Sustain proper valve morphology (prevent buckling and delamination)
Connect fibrosa and ventricularis
Absorb shear stress
Absorb compressive forces
Absorb shock of closure
Lubrication/minimize friction
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1.2
1.2.1

Glycosaminoglycans

Glycosaminoglycan Structure

Glycosaminoglycans (GAGs) are linear high molecular weight polysaccharides
that consist of repeating disaccharide units [29], which consist of an amino sugar and
typically an uronic acid residue [9]. The most common types of GAGs include
chondroitin sulfate (CS), dermatan sulfate (DS), heperan sulfate (HS), keratan sulfate
(KS) and unsulfated hyaluronan (HA) (Figure 6). HA, the most ubiquitous GAG in the
body, has essential roles in development, tissue organization and cell proliferation [30].
Furthermore, HA is the only GAG directly synthesized at the cell membrane, yielding
exceptionally large polymers that can be 10,000 disaccharide units in length [31]. The
sulfated GAGs are limited in size as they are synthesized inside the cells and excreted via
secretory vesicles. However, extracellular processing covalently links these chains to a
core protein, forming larger complexes known as proteoglycans (PGs) [30]. In contrast to
sulfated GAGs however, HA is not covalently attached to a protein core, but does
associate with PGs non-covalently via hyaluronan link proteins (Figure 6B) [17,30].
PGs are numerous in type and are classified based on their constituent GAG types
and sizes. Small PGs such as decorin and biglycan, also known as small leucin rich
proteoglycans (SLRPs), contain only one and two DS/CS chains, respectively [30,32].
The aggrecan family consists of large PGs that contain up to 100 CS chains and further
form complexes with HA to form superstructures (Figure 6A,B). The large abundance
and strong behavior of GAGs dominate the proteinacious core characteristics, yielding
similar behavioral characteristics of GAGs and PGs in solution [30].
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archy of GAGs and PGs. (A) Large PG with HA core to from
Figure 6. Structural hierarchy
aggregan. (B), Disaccharide
isaccharide GAG units: (C)
(C). Chondroitin
hondroitin sulfate, keratan sulfate and
hyaluronate (C) [33].
The presence of long GAG chains and large PGs in cartilage account for the
space-filling nature and large swelling pressures that fulfill the functional role of the
tissues in resisting compressive loads [30]. This behavior is brought about by the highly
anionic moieties of GAGs that generate high charge densities, which induce strong
electrostatic repulsive forces against each other on
n the same PG and between PGs (intra
(
and inter-molecular
molecular repulsion
repulsion, respectively) (Figure 7) [34,35]. Furthermore, the GAG
chains trap large solvent domains within the tissue ECM,, additionally imbibing water and
enhancing swelling
ling pressure [22]. Thus, the unfavorable increases in charge densities
and removal of water from the highly hydrophilic GAGs due to compression elicit a
strong viscoelastic response
response, whereby the tissue strain rebounds in a time dependent
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manner following the removal of load
load. This response has a viscous behavior in part due
to the micro flow of water throughout the ECM, which must absorb and resorb water
during compression and relaxation respectively [36].

The elastic component is

characterized by the steric and electrostatic repulsion of side chains mentioned and
collectively render the tissue viscoelastic under compressive loading,

oglycan intra and inter
inter-molecular repulsion;; (B) compression
Figure 7. (A) Glycosaminoglycan
induced repulsion and micro flow of water [35].

1.2.2

Valvular Glycosaminoglycans

In native aortic heart valves, a substantial amount of GAGs are present in all
a three
layers (~3.5% dry weight) [7,27]
[7,27]. HA, CS and DS represent the majority of all valvular
GAG content, mostly in the form of large HA meshes, associated PGs versican and
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SLRPs decorin [27]. PGs versican and decorin are comprised of sulfated CS/DS chains,
which account for ~60% of valvular GAGs, while HA accounts for ~30% [8,27].
1.2.2.1 Large GAGs
The various types of GAG and PGs are suited to provide distinctive functional
roles specific to the structures they associate with and which layer of leaflet they reside in
[3,8,17]. The spongiosa contains large quantities of the GAGs HA and the CS rich PGs
versican. The large HA chains in the spongiosa facilitate the non-covalent binding of
versican and are effectively held within the spongiosa by entangling themselves into the
fiber matrix of loosely arranged collagen and elastin [8,22]. These large GAGs and PGs
serve to fulfill the space-filling, compression resistant characteristic of the spongiosa vital
to valvular function.
1.2.2.2 Small GAGs
Decorin is a well characterized SLRP that resides in all layers of the heart valves,
as it is coupled with the ubiquitous collagen fiber [37,38]. Decorin is orthogonally
associated with collagen in “elastic shape modules” which facilitate the organization of
collagen structure as visualized by transmission electron microscopy (TEM) [38,39].
Scott et alii propose that the decorin GAG chains form interfibril anti-parallel links,
which are stabilized by hydrogen bonds and hydrophic interactions (Figure 8A). These
interfibril connections are apparent at intervals corresponding to the collagen D-banding
period of ~65nm and are the locations of amino acid patterns where PG ligand binding
can occur [39-41].
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section of collagen-GAG association;; (B) Longitudinal view of
Figure 8. (A) Cross-section
normal collagen-GAG
GAG association
association; (C) After applying compressive stress ; (D) During
osteoarthrosis [38].

fibers
ers during “the
Recall that compression is experienced by the collagen fib
unloaded” state (systole),, as illustrated by ((Figure 4) [14]. This compression is akin to
that induced
nduced in cartilaginous tissues; albeit relatively small, it still holds
hold important
implications in HVs which
hich undergo immense fatigue cycling. During osteoarthrosis,
osteoarthrosis loss
of GAGs precludes
es faulty collagen organization and leads to loss of “shape” that is
critical to the functional integrity of the tissues (Figure 8 B-D) [38]. Thus, loss of
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collagen-associated GAGs and disruption of collagen fibers in osteoarthrosis may be
reflective of the documented damages (collagen denaturation) that are induced during
fatigue to prosthetic heart valves [37,38,42,43]. Furthermore, decorin plays a critical role
in collagen formation and organization and is thus functionally important in maintaining
appropriate collagen spacing [37,38]. The ventricularis was found to have strong levels
of decorin and biglycan, which are known to associate with elastin forming ternary
complexes and micro-fibril associated glycoproteins [17]. Thus, GAGs and PGs play a
variety of roles reflective of their sizes and associations with other fibrous structures in
the heart valve ECM.

1.2.3

Glycosaminoglycan Function
1.2.3.1 Hydration

GAGs play numerous physiological roles including binding of growth factors,
cytokines, cells and even sterically protecting the surface of collagen from proteolysis
[40,44]. As mentioned, the spongiosa plays a critical role in normal heart valve function
facilitated by the highly anionic and hydrophilic GAGs, which maintain adequate
hydration in the leaflets. This hydration helps create the gel-like environment which
resists the compressive loads induced by bending and coaptation of leaflets during
valvular cycling and loading, respectively [3,5,6,8]. Furthermore, the GAG-induced
swelling pressures help maintain the appropriate morphological features necessary for
idyllic valve function [5]. This hydration is also important for the lubrication of matrix
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fibers, minimizing frictional damages that could occur to collagen structures [5]. Other
important mechanisms that may improve mechanical performance of collagen-GAG
interactions include viscous forces due to presence of PG and GAGs between collagen
fibrils that interact with collagen-associated decorin side chains [45,46].
1.2.3.2 Lateral Force Transfer
Collagen fibril to fibril (lateral) force transfer has previously been characterized in
tendons as a biomechanical function of GAGs [47].

These studies indicate that

increasing fibril length effectively leads to higher elastic moduli in tendons, as the longer
fibers permit larger numbers of GAGs to transmit the forces between fibrils [47].
However, others have yielded contradictory results, suggesting that removal of GAGs
from SLRPs do not significantly mediate dynamic elastic or viscoelastic (hysteresis)
properties of the tissues [48]. Nevertheless, these studies were performed in tendons
which contain relatively minuscule levels of GAGs, undermining the potentially more
significant role of lateral force transfer of GAGs and PGs in heart valves.
1.2.3.3 Energy Dissipation
The heterogeneous mixture of cells, GAGs and fibers collectively results in the
viscoelastic nature of the HVs. Viscoelastic materials exhibit both viscous and elastic
behaviors, resulting in time dependent strain. At the molecular level, this viscous
behavior is attributed to the movement or diffusion of atoms in an amorphous matrix,
which occurs in the ECM of the heart valve via the micro-flow of water absorbed and
resorbed by GAGs during loading and unloading respectively [36]. Thus, GAGs help
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dampen the loading energy in the interior of these tissues, which may help protect the
integrity of collagen [38,49]. Overall however, it is still evident that the functional role
of GAGs in native and particularly cross-linked heart valves are not yet fully
characterized [4].

1.3

Heart Valve Diseases and Failure

Normal cardiac function relies on efficient, unidirectional blood flow without
obstruction or regurgitation through the heart valves [3,7,50]. Valvular dysfunctions are
characterized by either stenosis or insufficiency and arise from a variety of valve
pathologies which may be present individually or concomitantly (Figure 9) [3,11,51,52].
Stenosis is a result of the obstructive opening of the heart valves, whereby the flow
conduit is narrowed during systole [18]. Insufficiency, also known as incompetence, is
characterized by regurgitative blood flow during diastole resulting from the incomplete
closure of the valves or tears in the leaflets themselves [50,51,53,54].

Valvular

dysfunctions may cause the heart to over-compensate, possibly resulting in ventricular
hypertrophy, dysfunction, morbidity and mortality [1,18,55].
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Figure 9. Heart valve dysfunction; valvular stenosis and insufficiency [12].
The underlying pathology of heart valve disease (HVD) is centered on aberrations
in VIC behavior. This could be due to congenital malformations in valve leaflets,
bacterial infections or a post-rheumatic auto-immune response.

Regardless of the

stimulus, alterations to VIC behavior preclude the cells of their vital role in remodeling
the structural architecture of the leaflets, offsetting the balance between synthesis,
organization and degradation of the ECM fibers and GAGs [3].
Heart valve disease can either be congenital or acquired [1,42,56,57]. Bicuspid
aortic valves are the most frequent congenital malformations (1% of population) and are
the cause of more than 2/3 of the cases of aortic stenosis in children and more than half in
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adults [11]. The bicuspid valve is stenotic due to its abnormal structure that impedes
flow and imposes higher stresses on the leaflets. This results in a higher prevalence of
calcification and structural damages in bicuspid leaflets, necessitating a higher frequency
of intervention with a heart valve replacement.

Other congenital defects in valve

architecture, such as irregular commissural attachments to the aortic root, malformed
leaflets and leaflet misalignments also present higher stresses on valves, which can lead
to dysfunction [50,57].
Acquired heart valve disease is commonly due to a variety of factors including
age, rheumatic fever, infection and atherosclerosis [3]. Hypertension and aging are often
accompanied by dilation of the ascending aorta, particularly the valve annulus, as a result
of elastin degradation. This may result in valvular insufficiency, as the valves are unable
to fully seal the larger orifice during diastole [50].
Heart valve disease acquired after rheumatic fever is prevalent in developing
countries lacking in adequate healthcare, yielding as many as 30 million affected children
and young adults [58-60]. Post-rheumatic heart valve disease is a consequence of an
over-compensated inflammatory response (auto-immune response), affecting connective
tissues including joints, tendons and heart valves. This response may cause the heart
valve leaflets to become thickened, scarred, stuck together and weakened, commonly
leading to mitral valve prolapsed and heart valve insufficiency [58,59].
Infection as result of acute infective endocarditis can result in the rapid
deterioration of valve tissue integrity. Bacterial adhesion and infiltration into the heart
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valves can cause detrimental inflammatory response, leading to both insufficiency and
stenosis [61].
Calcific aortic stenosis, the most common phenomena in valvular pathology, can
be both acquired and congenital. Age is the most common prerequisite in both acquired
and congenital calcification, while bi-leaflet aortic valves have a high prevalence of
developing calcification later in life [50].
Myxomatous mitral valve prolapse is another serious complication that affects
approximately 11% of men and 6% of women by age 70 [32,50]. Abnormal thickening
of the mitral leaflets renders them dysfunctional, causing them to lapse back into the left
atrium, leading to regurgitation, ventricular hypertrophy, morbidity and mortality. The
actual causes of this disease are largely unknown, but are thought to involve overcompensatory changes in the VIC phenotypes, resulting in an abnormally thickened
spongiosa, but a weakened fibrosa [3,14].
Collectively, heart valve disease leads to the death of 20,000 Americans per year
and contributes to an additional 40,000 deaths [18]. In 2003, an estimated 95,000 heart
valve replacement procedures were performed in the US alone and over 300,000
worldwide [1,3,18,55,62] Compounded with the rising population of elderly individuals,
the US market for heart valve surgeries and replacements are estimated to approach 1
billion dollars by the end of the decade [16]. Currently, there are estimated to be more
than 2 million individuals worldwide who are living with a prosthetic heart valve,
highlighting the pressing need to develop a long-lasting “ideal” heart valve [57].
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1.4

The Ideal Prosthetic Heart Valve

Replacement of a diseased heart valve is often life saving and beneficial to the
quality of one’s life. Ever since the introduction of the prosthetic heart valve (PHV)
substitution five decades ago, numerous improvements in design and implantation
techniques have been made [4,6,14,51]. Most of these large strides in improvements were
made within the first two decades and include the change from unstable formalin in the
chemical treatment of PHV tissue to the far superior GLUT-crosslinking [55].
Mechanical prostheses originally consisted of ball-and-cage valves and were quickly
improved to offer pyrolytic carbon-based tilting disc and bi-leaflet designs, which helped
significantly reduce the incidence of thrombo-embolic catastrophes [62,63].
However, current PHV complications still occur at 2-3% per patient-year [64] and
are reported to be as high as 60% after 10 years post-operatively [3,50,65]. Four decades
have passed since these large strides were implemented and it seems relatively
disheartening to see little improvement in the longevity of patients living with a PHV
since then.
Compounded with the large prevalence of HVDs that necessitates a heart valve
substitution, it is essential to develop a prosthetic heart valve that offers unaltered quality
and length of life [59].The criteria of an ideal prosthetic heart valves were established by
Harken in the 1960’s are listed in Table 2, highlighting the immense complexity in
constructing a device, as well as the long overdue
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Table 2. The Ideal Heart Valve Substitute [14]

Nonthrombogenic
Nonobstructive
Prompt and tight closure
Infection resistant
Chemically inert and nonhemolytic (does not damage blood elements)
Durable for extended intervals
Easily and permanently inserted into an appropriate physiologic site
Prosthesis-patient interface heals appropriately
Not annoying to the patient (noise free)

1.5

Mechanical Heart Valves

Currently, it is estimated that 50% of PHVs implanted around the world are
mechanical heart valves (MHVs) [3,18,55,66]. These passive structures utilize the
pressure differences induced by the heart to open and close at requisite time intervals.
The primary characteristic of these structures that render them excellent engineered
devices is their incredible high durability, generally lasting the life of the patient without
catastrophic mechanical failure. However, co-morbidities associated with anticoagulation and host-implant reactions to the device render them similar in overall patient
mortality rates to BHVs. Lastly, while exhibiting excellent durability, these valves are
further restricted from pregnant women and growing children [54,56,59,67].

23

1.5.1

Current Mechanical Heart Valves

Mechanical heart valves are derived from non-biological materials and all exhibit
a similar structure consisting of an occluder, a housing and a sewing ring. The occluder is
the movable structure which blocks flow during diastole and consists of either a ball, a
disc, or hinged leaflets. The housing orchestrates the dynamic alignment of the occluder
during cycling and the sewing ring facilitates the attachment of the device to the body
[63].
There are three main types of MHVs which include the ball-in cage, single
leaflet/tilting disc and bi-leaflet models (Figure 10). Each of these valve designs have
their own problematic tendencies, but collectively all exhibited similar failure rates
[63,67]. The ball-in-cage models were the first to enter the world of MHV substitutions
and were generally considered a gold standard for comparison with other valves. Tilting
disc valves became popular in the early 90’s, exhibiting low rates of thrombosis and
structural failures [63]. Lastly, the bi-leaflet models also exhibited excellent mechanical
durability and improved hemodynamics that attenuated the degrees of turbulent and
stagnant flow, further reducing the rate thrombogenic complications [63,68].
Improvements in all these differing designs have been made over time, as better materials
and material processing ( i.e. smooth surface pyrolitic carbons)
mechanical durability and decreased thrombogenicity [55,62,63].

offer increased

24

Figure 10. MHV Types: (A) Ball-in-cage; (B) Single-leaflet/tilting disc ; (C) Bi-leaflet
[63].
1.5.2

Failure in Mechanical Heart Valves

While exhibiting high durability and improved design features, patients with
MHVs still suffer similar mortality rates when compared to BHVs. Patients with these
valves are in the most danger of encountering thromboembolic complications, which
whi can
be exaggerated during other necessary surgical procedures and patient mismanagement of
the anti-coagulation
coagulation treatment [59]. The
he clinical event rates of thromboemobolic
complications with mechanical valves on anticoagulation therapy (ACT)
T) are similar to
those implanted with a BHV in the absence of the A
ACT [14].. Furthermore, persistent
ACT in pregnant women has been shown to yield a high rate (5
(5-10%)
10%) of birth defects,
which most women and doctors consider unacceptable [56,64,67].
The risk factors in MHVs that contribute to thromboembolism
olism include the
material composition, hemodynamic
hemodynamics and damaging effects on blood cells [55,57,6264,69].

High shear stress attributed to aberrant hemodymics contribute strongly to
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thrombosis formation, as these stresses are strong platelet activators [55,62,69]. In areas
of stagnant flow, direct contact of blood coagulation elements (Factor XII) to nonendothelialized surfaces also contribute to thrombus formation [62]. Furthermore, blood
cells may be agitated or ruptured in closing mechanical structures and when experiencing
high shear stresses across the moving mechanical leaflet, releasing thrombogenic factors
[62,69] .
Mechanical fatigue may lead to structural failure which is often acute and fatal in
MHVs. However, the transition of metal to pyrolitic carbon based leaflets and support
structures have yielded MHVs that are more resistance to cracking and failure [62].
Mechanical fatigue has also been attributed to a phenomenon known as cavitation,
whereby the flow over MHV surfaces yields transient micro-bubbles that implode,
leading to erosion and pitting on leaflet and housing structures that is conducive to
thrombus formation [55,70]. However, the overall occurrence of structural failure due to
mechanical fatigue has largely been eliminated, as evident by rare clinical reports within
the past 20 years [62,64].
Hemorrhage attributed to anti-coagulation therapy (ACT) is another concern for
MHV recipients. While the doses of ACT have been moderated due to reduced MHV
thrombogenicity, there are still serious complications of debilitating hemorrhaging
between 0.8 and 3.7% per year [71].
Pannus overgrowth onto the sewing ring can lead to valvular stenosis by
obstruction of mechanical leaflet movement and narrowing of the blood flow orifice [55].
Adhesion and infiltration of the sewing ring by macrophages and giant foreign body cells
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encourage a strong hyperplasic growth response by secreting potent growth factors and
cytokines [55]. This may lead to the irregular overgrowth of tissue around and even into
the valve prosthesis, narrowing the blood flow conduit and necessitating hazardous reoperation. Acute and catastrophic failure may result when the pannus growth interferes
with proper mechanical opening and closure, as seen in numerous clinical failures [72,73]

1.6
1.6.1

Human Tissue Valves

Cryo-preserved Cadaveric Homografts

These valve substitutes are obtained from cadavers and are frozen with a variety
crosslinking agents to reduce immunogenicity of the tissues. However, this process
devitalizes the cells and predisposes these valves to the same underlying failure
mechanism of crosslinked biological heart valves, whereby the ability of the tissue to
remodel itself is completely eliminated [2]. Limited availability of this type of
intervention further merits the search for an alternate, improved and unlimited supply of
valve substitutes.
1.6.2

Autograft Valves

In 1967, the Ross procedure was first described, consisting of the replacement of
the aortic valve with a patient’s own pulmonary valve [74]. The advantages of this type
of procedure are profound; the graft contains the patient’s own live tissue allowing
remodeling of ECM that is critical to valvular durability and exclusion of chronic anticoagulation therapy. Furthermore, this procedure has been considered the operation of
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choice for young children and infants, as the valve is able to grow and accompany the
changing anatomy of the patient [59]. However, the obvious disadvantage of swapping
one type of valvular disease with another (removal of the pulmonary valve precludes the
right side of the heart to valvular insufficiency) may also lead to patient morbidity and
mortality. Lastly, the technical complexity of the procedure limits the potential
candidates that would benefit from the Ross procedure [75].

1.7

Bioprosthetic Heart Valves

The use of BHVs has risen from 20% in the mid 90’s, to 40% in 2000 and currently
is estimated to make up more than half of the 300,000 valve replacement surgeries
performed worldwide every year [4,62]. BHVs display the antithesis of MHV pros and
cons as they are functional without the use of chronic anti-coagulation therapy, but
succumb to mechanical degradation and structural failure over time.

Thus, the

implantable demographic of BHVs are generally in first world patients above the age of
65, but are commonly used in younger demographics in developing countries as they are
incapable of safely administering ACT [18].
The advent of BHVs quickly followed the first MHV replacement in 1961, but was
quickly confirmed to contain inherent durability issues. The initial use of formaldehyde, a
mono-functional cross-linker, was not able to sufficiently mask the immunogenicity of
the tissues and led to rapid failure [76]. Not soon afterward, the substitution of
glutaraldehyde based crosslinkings came into existence. GLUT-crosslinked

valves

exhibited a significantly improved durability and were used on the first porcine aortic
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valve in 1969 [55,62]. Since then however, there have been little improvements made that
match the grandeur of switching to GLUT-crosslinking over 4 decades ago.
As the percentage of elderly individuals continues to rise, so will the number of
necessary BHVs substitutions. This demographic is more apt to receive a BHV instead of
a MHV because individuals at this age (65+) exhibit a relatively mild host-tissue
response and a life expectancy that is shorter than that of the BHV [55]. Younger
patients tend to have aggressive host-tissue reactions that destroy the tissue leaflets much
quicker than the elderly (nearly 100% failure in 5 years in those <35 years of age),
necessitating the implantation of a MHV instead [14]. However, in developing countries,
controlled anti-coagulation therapy is difficult and children are often implanted with a
BHV regardless, thus significantly limiting their longevity. Therein lies one of the
strongest motivations for creating a durable tissue based valve [14,62].
1.7.1

Current Bioprosthetic Heart Valves

BHVs consist of a metal or plastic frame or stent covered in a sewing ring for
attachment to aortic wall and a type of biological tissue that makes up the valve leaflets.
There are three main types of BHVs: the stented porcine aortic valve, the stentless
porcine valve and the stented bovine pericardial valves (Figure 11). These valves are
referred to as xenograft and heterograft valves and most often are derived porcine aortic
valves rather than pericardial valves [53]. Crosslinked porcine aortic valves offer
improved hemodynamics over pericardial valves, as they most closely imitate the original
aortic valve shape and dynamic function in-vivo. Pericardial based valves are derived
from a thin fibrous sac around the heart that provides lubrication from surrounding
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weight)), a relatively
organs.. The pericardium consists of mostly collagen (95% by dry weight
small composition
on of GAGs (<1%) and is crosslinked using the same GLUT-crosslinking
GLUT
as the porcine aortic valves [77]
[77].

tentless porcine aortic
Figure 11. BHV Types: (A) Stented porcine aortic valve; (B) Stentless
valve; (C) Stented
tented bovine pericardial valve [66].
1.7.2

Failure in Bioprosthetic Heart Valves

BHV functional durability is generally restricted to an upper limit around 12-15
years, with failure ultimately resulting from mechanical failure of the tissue leaflets [3,4].
Overall, these valves still exhibited some failure mechanisms
isms similar to those experienced
by mechanical valves. These include pannus overgrowth leading to sstenosis,, paravavlular
regurgitation and thromboem
thromboembolic complications. However, all of these failure modes
are relatively rare when compare
compared to the incidences
es induced by structural degeneration.
Structural
tructural failures due to both calcification and mechanical damages are gauged at
20-30% at 10 years and over 50% at 15 years in BHVs [53,64,78]. In those over 65 years
of age, failure rates at 10 years are as low as 10% [62] However, in children and young

30

adults this failure rate is greatly intensified (almost 100% after 5 years in patients under
35 years of age) and is a critical motivation for creating more durable BHVs [55,59].
These biological and mechanical alterations lead to four phenomena associated with the
failure of BHVs that are capable of acting independently or synergistically in causing
BHV failure (Table 3). It is important to note that the underlying causes of most BHV
failures is due to the absence of viable cells that are critical to the remodeling of the ECM
and maintenance of appropriate calcium levels.

Table 3. Major Failure Modes in BHVs
Structural degradation
Calcification
Inflammation
Pannus Overgrowth

Before implantation even occurs, structural degeneration occurs throughout
harvest, crosslinking and storage. Autolytic processes in temperature-shocked cells
contribute to serious cellular alterations that have been revealed to modulate degrees of
calcification [14,79]. Upon implantation, the tissue is “biolized”, as it absorbs a variety of
host cells and plasma elements. Plasma attachment and insudation along with
macrophage adhesion and infiltration lead to deposition of cell debris and calcium ions
both inside and on the surface of the tissues [3,50]. This deposition contributes to further
stiffening and morphological alterations of the tissue, compromising appropriate
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biomechanical function. Lastly, accelerated mechanical cycling of BHVs has been shown
to contribute to collagen denaturation and degradation [42,52,55,80].
1.7.2.1 Structural Degradation
The primary cause of BHV failure results from valve incompetence due to tearing
and perforations, accounting for as many as 75% of failed porcine prostheses in mitral
positions [55]. These damages are generally stress-induced during cyclic fatigue, but may
also occur due to enzymatic degradation of critical ECM components [8]. The most
detrimental damage that precludes BHVs to failure is that incurred by the fibrous ECM
component collagen. Structural degeneration of this main load-bearing fiber has been
documented in the kinking and tearing of collagen bundles and sheets, leading to leaflet
perforations and heart valve dysfunction (Figure 12B,C) [4,13,18].

Furthermore,

mechanical fatigue has been extensively shown to cause collagen damage and
denaturation [11,42,52]. Structural degeneration and loss of the space-filling, shearmodulating spongiosa is seen during the delamination of the delicate HV architecture
(Figure 12A). This is thought to further preclude the collagen fibers to structural
degeneration as their functional organization is significantly altered [79].
Large scale mechanical function alterations are also experienced in BHV leaflets,
as the distinct dilation of the annulur ring (base of the ascending aorta in which the valve
is located) during systole is restricted by a rigid stent structure. Thus, acute bending
angles at the commissural regions result in additional stresses on collagen fibers [16,55].
Reverse curvature and buckling in leaflets, which are already stiffer due to GLUT-
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crosslinking, impart additional mechanical stresses on collagen which previously have
been documented to yield collagen denaturation in BHVs [11,52].

Figure 12. Structural degeneration in BHVs: (A) Delamination; (B) Structural tear and
kinking; (C) Close-up of collagen bundles in the tear [81].

1.7.2.2 Calcification
It is interesting to note that calcification, while the most prominent and apparent
phenomenon associated with BHVs, affects less than half of clinically failed tissue valves
[55,62]. Thus, while previously the center of attention for improving BHV durability, it is
clear that other factors are contributing to the underlying mechanism of most BHV
failures, which are ultimately related to the structural degeneration of ECM fibers.
Nevertheless, calcification is a prominent and important mode of BHV failure and still
does merit the efforts of anti-calcification treatments.
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Figure 13. Calcification in BHV failure: (A) Insufficiency due to calcification induces
structural degeneration (arrows) and slight stenosis due to pannus overgrowth (“P”) ;(B)
Histological analysis of calcium deposits (arrows) [53].

The calcification of BHVs is due to a variety of factors, which include insufficient
immunogenic masking, residual cellular debris and exposed ECM fibers [51,53]. Inability
of devitalized cells to maintain low intracellular calcium levels leads to calcium
accumulation and potentiates calcification of nearby collagen and elastin [51,82,83].
Moreover, the leftover cellular debris (organelles, phospholipids) are further attractants of
calcium that amplify its deposition [84]. Collagen is adversely affected by the presence of
crystalline calcium (in the form of hydroxyapetite), which when coupled with mechanical
cycling induces structural damage [14,81]. Interestingly, elastin fibers calcify regardless
of aldehyde crosslinking, but collagen does so only in the presence of aldehyde
crosslinking [83,85]. With the growth of calcification, the tissue becomes significantly
stiffer and morphologically altered (Figure 13B) . Further structural damage results from
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sharp calcium crystals that enhance tearing and perforations of the otherwise soft and
pliable tissues (Figure 13A) [81,84].
Lastly, calcification alone may be severe enough to induce valvular failure, as
thicker, stiffer leaflets can lead to both stenosis and insufficiency. However, this has been
difficult to assess as most clinically failed valves have some degree of calcification
[51,53,82].

1.7.2.3 Inflammation
The inflammatory response has long been undermined as a significant factor in
BHV failure, but it is becoming more apparent that inflammatory reactions contribute
significantly to structural degradation of BHVs [55,62,86,87].

Remnant tissue

immunogenicity is still prevalent after GLUT-crosslinking, as unmasked membranebound receptors and glycoproteins continue to elicit cellular and humoral immune
responses [86-88]. There is thought be a link between this immune response and
calcification, driven by the deposition of infiltration, death and cellular depositions of
macrophages, which further potentiate structural degeneration during mechanical
function [88].
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Figure 14. Inflammatory response in BHVs: (A) Adhesion and infiltration of monocytes
(purple stain) in the fibrosa [53]; (B) Active phagocytosis of structural collagen by
macrophages [55].
An active immune response towards BHVs has been documented histologically
by the covering and infiltration of the tissues by inflammatory cells (Figure 14A)
[81,88]. Macrophages have a regulatory function in migrating through ECM structures
and devouring foreign entities, which requires matrix degrading and lytic enzymes.
Consequentially, macrophages have been directly visualized in degrading the “foreign
entities” that is the ECM of BHVs, as witnessed by direct visualization of phagocytosis
of collagen [55] and formation of dense infiltrates on non-flow surface (Figure 14) [53].
However, other studies offer opposing views, inciting that inflammatory reactions
are rare in the absence of infective endocarditis and that mild mononuclear cell reactions
are at times seen but their significance is uncertain [57].

Thus, the effect of the

inflammatory response on BHV failure is still uncertain and requires more investigation.
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1.7.2.4 Pannus overgrowth
Deposition of macrophages during the inflammatory response is thought to
contribute to the aggravated release of cytokines and growth factors that encourage
pannus overgrowth at the sewing stent (Figure 14A) [57,87,88]. Consequentially, pannus
overgrowth may compound with the other failure modes, as the excessive healing
response may produce additional areas of stagnant and turbulent flow. Stagnant flow may
yield by more cell adhesion, infiltration and additional overgrowth, forming an
portentous positive feedback loop [55]. Turbulent flow may induce additional stresses on
the BHV leaflets, further contributing to structural degeneration. Severe stenosis as result
of pannus overgrowth may lead to heart valve failure on its own, but is more likely to act
synergistically with the other modes to bring about this failure. This brings out the salient
point that all major failure modes rarely individually lead to HV failure, but rather do so
in cohorts with other failure mechanisms.

1.8

Glutaraldehyde Crosslinking in Bioprosthetic Heart Valves

Glutaraldehyde (GLUT) is an important and widely used chemical to stabilize
structural proteins, diminish tissue antigenicity, sterilize and store a variety of
bioprostheses including vascular grafts, artificial skin, tendons and heart valves [76,8992]. Ever since the advent of the first generation of GLUT-crosslinked BHVs, this
chemical has remained the industry standard for over 30 years [76,90]. However, while
GLUT-crosslinking has been successful in significantly improving and extending the
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lives of many individuals, it is clear that these improvements are not without
consequences that significantly limit their long-term durability.
1.8.1

The Glutaraldehyde Molecule

GLUT is an aliphatic dialdehyde that forms a stable Schiff-base bond between
amine functional groups located on hydroxylisine/lysine collagen proteins, thus
stabilizing collagen fibers against proteolytic degradation [40,89,90,92]. The monomeric
GLUT molecule is postulated to form a crosslinking distance ~ 7.5 Å between their
amino nitrogen atoms [93]. Depending on its concentration in aqueous solutions, GLUT
undergoes various amounts of polymerization via aldol condensation reactions to yield
stable end products of various size and geometry [76,89,90].Thus, GLUT is able to crosslink proteins that are located a variety of distances from each other [76,90] (Figure
15B,C).
1.8.2

Crosslinking of Collagen

Collagen is composed of a complex hierarchy of organization (Figure 15A).
Molecular collagen, or tropocollagen, consists of three helical left-handed polypeptide
strands that approximately 15 Ä in diameter and 3000 Ä long [41]. Tropocollagen is
further twisted together into a right handed triple helix (microfibril) [41,95]. Microfibrils
associate together in a right handed super-triple helix (fibril), which exhibits the
characteristic D-Banding due to staggered alignment of microfibrils [96]. Finally, fibrils
further associate into large fibers and larger fiber bundles. These hierarchical
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GLUT-crosslinking
crosslinking within
identifications are important for disclosing the mechanism of GLUT
this complex protein.

.
Figure 15. Collagen crosslinking via GLUT: (A) Collagen structural hierarchy;
hierarchy (B)
GLUT-crosslinking of collagen microfibril
microfibril; (C) Proposed GLUT-crosslinking
crosslinking bridges
between tropocollagen [91,94]
[91,94].
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As such, locations of GLUT-crosslinking of collagen are diverse and complex,
occurring at various trophic levels of collagen organization and at relatively different
densities. Intra-helical cross-links are less likely, as appositional cross-linkable distances
between amine groups on the same helix are too small [41,89,93]. Crosslinking is more
likely to occur at the inter-tropocollagen level, the inter-microfibril and inter-fibril levels
when appositional spacing is close enough [90,95]. Ultrastructural analysis using atomic
force microscopy has visualized the decreased D-banding pattern illustrating the actual
contraction of collagen after GLUT-crosslinking, supporting the hypothesis that collagen
is cross-linked at an interfibril level. [96, 97].
1.8.3

Benefits of GLUT-crosslinking

GLUT-crosslinking induces a variety of alterations to the native heart valves that
are both beneficial and detrimental to heart valve durability.

The most prominent

benefits include the preservation of the critical ECM components collagen, responsible
for maintaining the bulk of the structural and functional roles in heart valves. As
mentioned, GLUT stabilizes the critical structural protein (collagen) against enzymatic
degradation and denaturation. Furthermore, GLUT attenuates the immunogenicity of
native porcine valves, mitigating the inflammatory reaction that would otherwise quickly
destroy the valves [90].
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1.8.4

Consequences of GLUT-crosslinking
1.8.4.1 Devitalization

While the benefits of GLUT-crosslinking have improved the lives of many, the
encumbering limitations of BHVs are apparent to those who receive them. GLUT makes
significant contributions to valvular failure; the most prominent of which is the
devitalization of cellular components [55]. This precludes the cellular remodeling of the
ECM components which are so vital to the durability of the tissues [1-3,55,62,82].
Furthermore, normal cellular function that maintains low intracellular calcium levels is
abolished, contributing to calcification. Endothelial cells, once devitalized, are stripped
and lost from the surface, exposing sub-endothelial ECM components to potentially
damaging blood elements and cells [3,14,51]. Devitalization also precludes a critical
remodeling process of breakdown and scavenging of previous cellular and ECM
components. Resultant deposition and accumulation of cell debris has been shown to
quickly lead to calcification in these connective tissues [82,98].

1.8.4.2 Toxicity
GLUT-crosslinking also renders these BHVs cytotoxic, discouraging reendotheliazation and attenuating the scavenging efforts of absorbed macrophages [82].
Furthermore, the subsequent death and accumulation of the macrophages themselves add
to the total cell debris, further potentiating calcification [88].
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1.8.4.3 Mechanical compromise
Perhaps the most detrimental consequences of GLUT-crosslinking are the
biomechanical consequences of a “locked” ECM microstructure, which heavily impinges
on the normal micro-structural shearing between the fibrosa and ventricularis
[4,11,14,99]. This has been characterized extensively, revealing altered degrees of
shearing as a consequence of GLUT-crosslinking, increased stiffness during biaxial
tensile testing and substantially increased flexural stiffness [4,5,25,28,100]. This
excessive stiffening is detrimental to collagen integrity, as it imposes altered and more
severe stresses on the fibers that further potentiate their denaturation during fatigue
cycling [42]. Furthermore, certain preparation methodologies that induced transvalvular
pressures during crosslinking remove collagen crimping and corrugations that are
necessary for proper valve function [4,19,43,99]. This locked, un-crimped microstructure
of collagen fibers must still undergo compression during systole. However, unable to
reform the natural crimping morphology, these fibers undergo microscopic buckling and
macroscopic kinking that further denatures collagen and leads to structural degeneration
(Figure 12) [14,81]. Thus, GLUT crosslinking has been shown to yield valves that do not
open smoothly but bend and kink, creating areas of high flexure that when compounded
with fatigue can lead to structural degeneration and failure [14,81].
1.8.4.4 Calcification
It is clear that the consequences of cell devitalization further contribute
significantly to calcification. However, GLUT aldehyde remnants, including dialdehdyes
and polymerization products are also thought to potentiate calcification [55,82]. Further
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calcification of ECM fibers is induced along collagen fibers where GAGs normally
reside, which are thought to additionally protect collagen from calcification [82].

1.9

Glycosaminoglycan Loss in Bioprosthetic Heart Valves

GLUT-crosslinking fails to stabilize other critical extracellular matrix components,
including elastin and glycosaminoglycans (GAGs), due to the lack of amine
functionalities necessary for GLUT-crosslinking [5,42,101]. The loss of GAGs has been
extensively characterized to occur not only during in-vivo implantation, but also during
the processing, storage and fatiguing of BHVs [5,7,8,22,27,101].
We have previously characterized decreased hydration in cusps due to enzymeinduced GAG loss which have led to biomechanical consequences including increased
tissue buckling and a 60% increase in flexural rigidity [5,9]. Furthermore, it is shown
that reduced internal shear in BHVs is not only a consequence of the “locked” ECM
architecture due to crosslinking, but an additional biomechanical effect decreased tissue
hydration [25]. Lastly, GAGs have been characterized to play an additionally role prevent
calcium deposition by chelating calcium and preventing hydroxyapatite nucleation
[91,102,103].
1.10 Heart Valve Biomechanics
The heart valve will undergo over 40 million cycles per year in the average adult
and necessitates complex biomechanical structure and function to meet these demands
[3]. Valves will experience a variety of forces and dynamic behaviors that include surface
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shear from blood flow, tensile loading during closure and flexure as the valves transition
between the open and closed state [1,3,5,14,28]. Characterizations of tensile and flexural
loading have been performed using planar uniaxial, biaxial tensile and flexural testing
[11,104,105]. These analyses are important, as they have revealed that areas of high
tensile and bending stresses fail with the highest frequencies, highlighting significant
areas for improved valve design [28].
1.10.1 Tensile Characterization
Planar uniaxial characterizations of valvular tissues reveal a marked decrease in
the extensibility of the tissues which are attributed to the “locking” of collagen fibers in
an un-crimped state [13]. However, testing uniaxially cannot account for dynamic strains
induced in both axes during normal cardiac function and thus necessitated more
appropriate modeling analyses [4,11]. Planar biaxial tensile characterization has met this
demand and has revealed a complex, highly anistropic behavior in heart valves that is a
byproduct of the coupling of layers which each exhibit differing mechanical behaviors
[11,104,106]. During biaxial analysis, tensile forces of the same magnitude were applied
in the radial and circumferential directions and resultant strains recorded (Figure 16)
[104,106]. Results conclude that circumferential strains are much smaller than radial
strains and that GLUT-crosslinked leaflets were much less extensible than native leaflets
in all directions [106]. These deformations occur from changes in the internal structure
and include the rotation and un-crimping of collagen fibers circumferentially and
stretching of the elastin fibers radially [2,11,14,50].
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Figure 16. Biaxial tensile testing: (A) Leaflet section; (B) Sample set up; (C) Tension
versus Green’s strain (accounts for both collagen rotation and extension) in fresh and
crosslinked leaflets [11].
1.10.2 Hysteresis
Energy dissipation is a key mechanical function of ECM in numerous tissues [46].
The viscoelastic character exhibited in heart valves has been shown to be an outcome of
the viscous matrix of water and GAGs surrounding the elastic collagen fibers [11].
Analysis of tissue valve relaxation (unloading) results in stress dissipation (hysteresis)
due to sliding mechanisms facilitated of collagen-associated GAGs and PGs [1,11].
Energy dissipation may be important for maintaining collagen integrity and preventing
collagen damage, loss of which may be biomechanically consequential to valvular
durability [3].
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1.10.3 Flexure
Flexural analysis allows insight into the mechanical behavior during-crosslinked
leaflet bending mentioned [5,105,107]. Flexure offers important insight into changes in
stiffness at low-stress strain levels that are masked by collagen tensile resistance and the
ability to assess the contributions of the layers individually. Results from this analytical
method have shown that flexural rigidity, an indicator of tissue compliancy, are markedly
reduced after GLUT-crosslinking, fatigue cycling and GAG loss and resultant structural
delamination (Figure 12A) [5,107]. This increased flexural rigidity is posited to
contribute to regions of focal flexural fatigue, structural damage and valvular failure
(Figure 17) [107]. This indicates the need for chemical crosslinking techniques that
induce minimal alterations to original tissue compliancy and maintain that compliancy
throughout fatigue cycling [107].

Figure 17. 3-D imaging of curvature (k2) of leaflets during opening as viewed in (A)
Native leaflets and (B) GLUT-crosslinked leaflets (arrow points to area of focal flexural
fatigue) [107].
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1.11 Highlights
The heart valve has evolved a complex biomechanical structure that enables it to
withstand billions of cycles. This durability is largely abutted by the constant remodeling
and resynthesis of ECM components collagen, elastin and GAGs by living valvular
interstitial cells. Aberrations in this cellular remodeling can lead to dysfunctional valves
that necessitate a valve substitution, which generally consists of either a bioprosthetic or
mechanical heart valve. While bioprosthetic heart valves do not require chronic anticoagulation therapy, they regrettably succumb to structural degradation that results in
patient mortality rates similar to mechanical heart valves. GAGs are posited as important
physiological and biomechanical components of the heart valve and their loss during the
implantation and cycling of BHVs is purported to have adverse biomechanical effects.
These consequences include, but are not limited to, decreased hydration, loss of tissue
compliancy, altered leaflet morphology and compromise of collagen organization and
mechanical integrity. Lastly, biomechanical characterizations suggest that leaflet
compliance is of critical important to BHV durability. Thus, functional stabilization of
GAGs using novel chemical fixation chemistries that do not significantly stiffen valve
leaflets may enhance BHV durability and the quality of life of the individuals in which
they reside.
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CHAPTER 2: RESEARCH RATIONALE
2.1

Overview

While many improvements have been made in the BHV design over the past four
decades, there still remain critical flaws that render these valves dysfunctional within 1215 years. Thus, the ideal bioprosthetic heart valve has yet to be achieved and merits the
search for design improvements to create a prosthetic valve that not only improves the
quality of life, but last the lifetime of the patient.
Improved ECM preservation is critical for aspiring to the “ideal” bioprosthetic heart
valve. Structural GAG loss and consequential biomechanical alterations are posited as
having serious implication for structural degeneration. Specifically, collagen fibers are
damaged during function, as their surrounding and supportive GAG structures are
degraded and lost. GAG loss occurs through a variety of modes that include fatigue
induced, enzymatic and simple diffusion out of the heart valves. Thus, their functional
stability is not secured by current GLUT-crosslinking. Collectively, improper GAG
stabilization by GLUT and its subsequent loss threatens collagen integrity, which may
lead to structural tears and perforations, valve dysfunction, patient morbidity and
mortality. We propose that stabilizing GAGs will attenuate this hierarchy of interrelated
effects and hopefully bring us one step closer to achieving an ideal BHV. To accomplish
this, a hyaluronidase inhibitor, neomycin, will be incorporated into the tissues and
assessed for its ability to actively attenuate GAGase degradation.
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2.2
2.2.1

Specific Research Aims

Aim I: Does NG crosslinking stabilize valvular GAGs in BHVs?

Hypothesis: Neomycin binding to nearby collagen structures via GLUT-crosslinking may
actively inhibit GAGase activity, preventing degradation of nearby GAG structures and
loss from the tissues. Furthermore, enhanced crosslinking may help stabilize these
components during in-vitro enzymatic, accelerated cyclic fatigue, storage and in-vivo
implantation induced GAG loss.
Experimental Plan: Porcine aortic heart valves will be crosslinked using various
concentrations of neomycin and subjected to GAGase incubation.

The optimized

concentration of neomycin crosslinking will be used to assess GAG stability during
various induced modes of GAG loss: in-vitro storage, fatigue and in-vivo implantation.
Leafletl GAG content will be quantitatively assessed using hexosamine and DMMB
assays and qualitatively analyzed via histology and transmission electron microscopy
(TEM).

2.2.2

Aim II: Does the presence of neomycin enhance GLUT-crosslinking in
BHVs?

Hypothesis: Neomycin may potentiate GLUT-crosslinking because of its six available
amine functionalities. This might affect other tissue characteristics, including enzymatic
resistance of collagen and elastin, tissue hydration and collagen denaturation
temperatures.
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Experimental Plan: NG-crosslinked leaflets will be subjected to collagenase and elastase
as indirect measurements of GLUT-crosslinking. Differential Scanning Calorimetry will
be utilized to assess any increases in collagen denaturation temperatures, utilizing both
hydrated and dehydrated samples.
2.2.3

Aim III: Does NG crosslinking maintain compliant biomechanical behavior
in BHVs?

Hypothesis: While the binding of neomycin may improve GAG stability, enhanced
crosslinking may entail adverse biomechanical consequences.
Experimental Plan: NG-crosslinked leaflets will be analyzed using biaxial stress-strain
analysis to analyze biomechanical behaviors at both low and high tension. Comparative
analyses of biomechanical benefits of GAG preservation will be pitted against potential
detrimental effects of NG crosslinking in BHVs.
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CHAPTER 3: MATERIALS AND METHODS
3.1

Materials

Ammonium acetate, chondroitinase ABC from Proteus vulgaris, collagenase type
VII from Clostridium histolyticum, 1,9 –dimethylmethylene blue (DMMB), (D+)
glucosamine HCl, hyaluronidase type IV-S from bovine testes, and neomycin trisulfate
hydrate were all purchased from Sigma-Aldrich Corp (St. Louis, MO). EM Grade
Glutaraldehyde- 50% wt. in H20 , osmium tetroxide (OsO4), propylene oxide, toluidine
blue O and LR White Resin were purchased from Polysciences Inc. (Warrington, PA).
Acetyl

acetone,

p-dimethylaminobenzaldehyde,

4-(2-hydroxyethyl)-1-

piperazineethanesulfonic acid (HEPES), were purchase from Fisher Scientific (Fair
Lawn, NJ). 2-(N-morpholino) ethanesulfonic acid (MES), was purchased from Acros
Organics, (Morris Plains, NJ).
3.2
3.2.1

Methods

Acquisition and Crosslinking of Porcine Heart Valves

Fresh porcine hearts were acquired at a local abattoir (Snow Creek Meat
Processing, Seneca, SC). Valves were excised on site, by cutting along the aortic roots
and just above the aortic sinuses. Ice cold phosphate buffered saline (PBS) was used to
transport the valves back to the lab and to thoroughly rinse the valves. Valves were crosslinked within 4 hours of acquisition in the following methodologies:
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GLUT- Valves were placed in 0.6% glutaraldehyde (GLUT) in 50 mM HEPES buffered
saline solution at pH 7.4, ambient temperature. After 24h, the solution was replaced by
0.2% GLUT solution for an additional 6 days.

NG- Valves were incubated in a solution of 1mM neomycin trisulfate in 50 mM MES
buffered solution at pH 5.5, ambient temperature under constant orbital shaking for 1h.
This was followed by standard GLUT-crosslinking as shown.

All chemical treatments utilize 100 ml of solution per valve. All valves were
crosslinked in the diastolic morphology (closed state) by inserting a cotton ball into each
leaflet.
3.2.2

Optimization of Neomycin Concentration

Valves were immersed in concentrations of 50 µM to 1 mM of NG. GLUTcrosslinking alone and fresh leaflets were used as controls. Samples were subjected to
GAG-degrading enzymes (3.2.3) and then analyzed using prescribed hexosamine,
DMMB and histological assays. (n=4)

3.2.3

GAG Stability against Enzymatic Degradation

Aortic valve leaflets were carefully excised from their aortic walls and washed
thoroughly in 100 mM ammonium acetate buffer (AAB), at pH 7.0 for 3 x 5 min. The
leaflets were then cut in half symmetrically and one half was incubated in 1.2 ml of 100
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mM AAB at pH 7.0 as a control, while the other half was incubated in 1.2 ml of GAG-

degrading enzyme solution (GAGase - 1.2 ml of 5.0 U/ml Hyaluronidase and 0.1 U/ml
chondroitinase in 100 mM AAB, pH 7.0). Both groups underwent vigorous shaking at
37ºC for 24h. Following the 24h incubation, leaflets were rinsed in distilled water for 3 x
5 min. The buffer and enzymatic solutions are saved for further DMMB analyses.

3.2.4

GAG Quantification by Hexosamine Analysis

Total tissue hexosamines were quantified as previously prescribed [5,9,108].
Lyophilized leaflets were weighed, then hydrolyzed in 2 ml of 2 M HCl for 20 hours at
95ºC, dried under nitrogen gas and re-suspended in 2 ml of 1 M NaCl. These were reacted
with 3% acetylacetone in 1.25 M sodium carbonate solution, 4 ml of absolute ethanol and
2 ml of Ehrlich’s reagent (.18 M p-diemethyl-aminobenzaldehyde, 50% ethanol in 3.0 N
HCl). Incubation at room temperature for 45 minutes was allotted for the reaction to
yield a color product indicative of hexosamine quantities, which was read for absorbance
at 540nm. A set of

D (+) glucosamine solutions were used controls (1-200µg) and all

values were normalized to their respective dry tissue weights. Hexosamine assay
accounts for ~90µg /10mg of non-GAG hexosamines, thus we subtracted this from data
as done previously [5,6].
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3.2.5

GAG quantification by Dimethylmethylene Blue

DMMB assay was used as described previously to determine total amounts of
sulfated GAG’s leached out of the tissue and into the enzyme or buffer solution [23,109].
Briefly, 20µL of each sample (either enzyme or buffer), 30 µL of PBE buffer (100 mM
Na2HPO4) 200 µL of DMMB reagent (40mM NaCl, 40mM glycine, 46 µM DMMB, pH
3.0) were pipetted into a 96 well plate. Chondroitin sulfate standards were used as
controls (0-1.25µg). Spectrophotometric analysis was performed at 525 nm and executed
immediately after addition of DMMB reagent, as formed DMMB dye-GAG complex has
been shown to be unstable [109,110]

3.2.6

Collagen and Elastin Stability

Resistance of leaflets to enzymatic degradation of collagen and elastin were
assessed for the different groups. Leaflets were rinsed, lyophilized and weighed. The
leaflets were then treated with porcine pancreatic elastase or Type VII collagenase as
described previously [111]. Briefly, half the leaflets were placed in 1.2 ml of 5.0 U/ml
elastase (100mM Tris buffer, 1mM CaCl2, .02% NaN3). The other halves were placed in
1.2 mL of 150 U/ml collagenase (50 mM CaCl2, .02% NaN3, pH 8.0). Both groups were
incubated at 37ºC for 24 h under constant shaking at 650 RPM. Samples were
subsequently rinsed, lyophilized and weighed to obtain the final dry weight. The percent
weight loss is calculated from the initial and final dry weights before and after enzymatic
treatment for each group.
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3.2.7

Differential Scanning Calorimetry
3.2.7.1 Method 1

DSC was performed as on hydrated BHV leaflets to assess collagen denaturation
temperatures (Td), previously defined as the temperature measured at the endothermic
peak [42]. Samples between 7-10 mg (wet weight) are excised from the central belly
region of the leaflets, blotted with tissue paper and placed into hermetically sealed pans
to prevent water evaporation. Samples were heated at 10ºC min-1 for 10 minutes, starting
at 20ºC until 120ºC and measured afterward to ensure no water escaped. The weight of
samples and pans were weighed before and after to ensure no weight loss occurred due to
water evaporation.
3.2.7.2 Method 2
DSC was performed on dehydrated BHVs at higher temperatures as previously
described in the literature [112-114]. Samples are excised from the central belly region of
the leaflets, lyophilized for 24 hours, measured for dry weight and placed in DSC pans.
Samples were heated at 20ºC min-1 starting at 30ºC until 150 ºC to evaporate off any
residual water. Tissues were then ramped up to 270ºC at 20 ºC min-1, where collagen Td
was recorded around 230 ºC. The weight of samples and pans were weight before and
after to ensure no weight loss occurred due to water evaporation.
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3.2.7.3 Thermal Analysis
DSC software (Thermal Analysis) was used to analyze the peaks and determine
collagen Td. Onset, inflection and peak values of thermal denaturation were assessed as
shown in Figure 18.

Figure 18. DSC data analysis using Thermal Analysis to find collagen Td (A) and
consistently characterize the onset, inflection and end of Td (B).
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3.2.8

Measurement of Water Content and Rehydration Capacity

Initial hydrated tissue weights were appropriated by drying of the exterior
surfaces of the leaflet tissue consistently using three stacked tissue papers folded in half.
The wet weight of each leaflet was recorded prior to lyophilization.

Following a

lyophilization period of 24h, the leaflet dry weights were recorded. Initial water content
was then calculated as follows:

Water Content =

Wet Tissue Weight − Dry Tissue Weight
Wet Tissue Weight

The rehydration capacity of crosslinked leaflet tissue was determined by
rehydrating the tissue samples in 1.5ml of deionized water for 24h at 4oC. The wet
weight was determined and the rehydration capacity was calculated as follows:

Re hydration Capacity =

3.2.9

Re hydrated Tissue Weight − Dry Tissue Weight
Dry Tissue Weight

Histological Assessment

Representative sections of the central belly regions of the leaflets were excised,
embedded in paraffin wax and sectioned for light microscopy analysis. Alcian blue
staining followed by nuclear fast red counter stain was performed, with intense blue
indicating the presence of GAGs. Digital photographs were taken approximately midway
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between leaflet base and tip using a Zeiss Axioskop 2 Plus (Carl Zeiss MicroImaging,
Inc., Thornwood, NY) in conjunction with SPOT Advanced software.
3.2.10 In-vitro Accelerated Cyclic Fatigue Testing
BHV’s were subjected to accelerated cyclic testing to assess GAG stability
against fatigue (Figure 19). Appropriately sized valves were selected, trimmed and
securely sutured into Delrin stents. The valves were then mounted into a compliant
silicon tubing vessel (25 mm inner diameter, 2 mm thick, 100 mm long) and inserted into
a Dynatek Dalta M6 accelerated fatigue tester. Circulating fluid consisted of 0.02% NaN3

Figure 19: In-vitro accelerated cyclic fatigue testing: (A) Unstented porcine heart valves;
(B,C) Porcine heart valves sutured into stents; (D) Compliant silicone vessel; (E) Valve
inserted into testing chamber; (F) Set of 6 stented porcine heart valves undergoing
accelerated fatigue testing; (G) Proper closure (coaptation) and opening.
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in PBS as recommended and used industrially (Dynatek Dalta). Three NG and three
GLUT valves were mounted and tested at ~720 cyclesmin-1 for 50 million cycles (n=9
leaflets per group), corresponding to ~1.5 years in the average adult. Stroboscopic
inspection for leaflet damages, along with observation for consistent cross-valvular
pressure gradients were made daily. After cycling, leaflets were analyzed for GAG
content using hexosamine and DMMB analysis along with qualitative histological
analysis.
3.2.11 Storage Studies
The GAG content of leaflets was tested after 90, 180 and 400 days of storage in
0.2% GLUT at room temperature. Resistance to enzymatic degradation of GAGs was
also performed at these time points and analyzed for GAG content using hexosamine
assay.

3.2.12 Transmission Electron Microscopy (TEM)
Representative 1cm2 tissue sections of the central belly regions were excised as
they best represent the leaflet structure, particularly in the study of the GAG rich
spongiosa layer [8]. These section were then cut into squares approximately 1 mm2,
placed in 2.0% GLUT in 0.1 M cacodylate buffer pH 7.2 containing 0.2% toluidine blue
O for 24 h at 4ºC. Tissues were subsequently brought to room temperature, rinsed in
0.1% toluidine blue in 0.1 M cacodylate buffer pH 7.2 and then treated for 60 min with
1% OsO4 and 0.1% toluidine blue O in 0.1 M cacodylate buffer, pH 7.2. Samples were
dehydrated through increasing ethanol concentrations and finally embedded in LR White
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Medium Resin (Polysciences Inc. Warrington, PA) . Ultra-thin section (70-100nm) were
made in the plane of the leaflets and collected on formvar-supported copper grids and
stained with uranyl acetate followed by lead citrate. Analysis was performed on a Hitachi
H7000 transmission electron microscope operated at 100kV using high contrast mode at
the Electron Microscope Facility (Research Park, Clemson, SC).
3.2.13 Biaxial Biomechanical Analysis
These tests were performed by collaborative efforts of Brandon T. Mikulis and
Dr. Michael S. Sacks at the University of Pittsburg. Briefly, NG and GLUT-crosslinked
leaflets were analyzed via biaxial tensile testing, allowing insight into valve behaviors
under planer stress(n=12). These experimental methods are outlined in the literature
[1,4,11,104,106].
3.2.14 Statistical Analysis
All data was expressed as a mean ± standard error of the mean (SEM). Statistical
analysis was performed using single factor analysis of variance (ANOVA). Differences
between the means were determined using least-significant difference with a P-value of
0.05.
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4
4.1

CHAPTER 4: RESULTS
Effective NG Concentration

The resistance of BHV leaflets cross-linked with various concentrations of NG
against enzymatic degradation of GAGs was assessed by incubating crosslinked leaflets
in GAGase solution (5 U/ml Hyaluronidase and .1 U/ml Chondroitinase) [5].
Hexosamine analysis of leaflet GAG content after GAGase incubation revealed
significant amounts (p<.05) of GAG loss versus buffered controls in concentrations of
NG below 1 mM (Figure 20). In fresh leaflets, 24h of GAGase incubation led to a loss of
72% of GAGs, highlighting the profound degree and efficacy of GAGase-induced GAG
loss. GLUT-crosslinked leaflets similarly suffered severe GAG loss (53% ), but did
exhibit an improved resistance to enzymatic GAG loss when compared to fresh tissues.
Leaflets incubated in 50 mM MES buffer without neomycin followed by the standard
GLUT-crosslinking were analyzed as an additional control and revealed similar degrees
of GAG loss comparative to GLUT-crosslinking. Concentration of neomycin ranging
from 25 µM to 500 µM revealed gradually less, but statistically significant amounts of
GAG loss, while 1mM NG-crosslinked leaflets resulted in only 6.4% ± 6.9% of GAG loss
which was statistically insignificant (p>0.05) .
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Figure 20: Hexosamine analysis of GAG content: Optimization
concentration for effective GAG degrading enzyme resistance
resistance.. (n=4 per group,*
group indicates
significant difference, p<0.05).
DMMB analysis was used to quantify the sulfated GAGs that leached out into the
surrounding solution during incubation in GAGase and buffered controls (Figure 21).
Note however that these reported values are less than that reported by hexosamine due to
the inability of the DMMB dye to bind the un
un-sulfated
sulfated GAG hyaluronan, which makes up
more than 30% of leaflet GAGs. Regardless, results from DMMB compliment the
hexosamine analysis well, as Fresh and GLUT-crosslinked leafletss exposed to GAGase
released significant amounts of sulfated GAG loss (~25% and 20% total GAG loss
respectively), while increasing
easing concentrations of NG crosslinking exhibited decreasing
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amounts of GAG loss. At 1mM of NG crosslinking, leaflets revealed a five--fold decrease
in leached GAGs duringg GAGase incubation versus GLUT
GLUT–crosslinked leaflets (p<0.05).
Thus, 1 mM of NG was chosen
osen in all other analyses for its ability to yield statistically
insignificant GAGase-induced
induced GAG loss, as assessed by both hexosamine and DMMB
assays.

Undigested

µg sulfated GAGs/10mg dry tissue

50.0

GAG Digested

40.0

30.0

20.0

10.0

0.0
Fresh

GLUTMES
MES Buffer 25µM

50µM

250µM

500µM 1mM NG

Figure 21. DMMB quantification of GAG’s leached into solution: Optimization of
neomycin concentration for effective GAG degrading enzyme resistance. (n=4 per group,
* indicates significant difference, p<0.05).
Histological evaluations for GAGs using Alcian Blue staining confirmed
quantitative results, with intense blu
bluee staining illustrating significant retention of GAGs
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crosslinked leaflets exposed to enzymatic degradation (Figure
Figure 22D), while
in (1mM) NG-crosslinked
GLUT-crosslinked leafletss suffered significant losses of GAGs ((Figure 22B).
).

Figure 22.. Histological evaluation be
before and after GAGase incubation (Alcian Blue
staining indicates the presence of GAGs
GAGs); (A) Undigested GLUT-crosslinked
crosslinked leaflets;(B)
leaflet
GLUT-crosslinked leafletss after GAGase incubation; (C) Undigested NG-crosslinked
NG
leaflets; (D) NG-crosslinked
crosslinked leaflets after GAGase incubation. Original magnifications
X100 (n=4).
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4.2

GAG Stability in Storage

GAG content of GLUT and NG leaflets stored in 0.2% GLUT at ambient
temperatures was measured using hexosamine analysis. Over the course of 400 days,
groups were analyzed for GAG content to assess time-dependent GAG loss. Furthermore,
corresponding stored groups were analyzed for GAGase-induced GAG loss after storage
to assess whether NG crosslinking maintained GAGase resistance over time.

100
NG Stored
GLUT Stored

% GAG Loss

75

50

25

0
0

100

200
Days in storage

300

400

Figure 23. Percent GAG loss after prolonged storage in 0.2% GLUT at room temperature
(GAG content measure by hexosamine analysis, n=6)
Over the course of 400 days, NG-crosslinked leaflets lost an average of 23.4% ±
4.9% of its original GAG content, while GLUT-crosslinked leaflets lost around twice as
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much (54.1% ± 6.95%) (Figure 23). This revealed NG crosslinking was more effective
at preserving GAGs than GLUT during storage (p<0.05), but also indicated that a
reduced but evident rate of GAG loss still existed in NG-crosslinked leaflets due to
general diffusion/leaching of un-crosslinked GAGs.
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-25
Days in storage

Figure 24. Percent GAG loss after prolonged storage in 0.2% GLUT and GAGase
incubation (GAG content measure by hexosamine analysis, n=6)
Stored GLUT-crosslinked leaflets subject to GAGase incubation exhibited an
interesting downward trend in % GAG loss. Initially, GLUT stored leaflets revealed
profound percentages of GAGase induced GAG loss. However, after 400 days GLUT
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leaflets exposed to GAGase revealed no significant losses in GAGs, due to the fact that
there were no GAGs left in the tissues to be lost during GAGase incubation because they
were already lost during storage. NG-crosslinked leaflets at all storage points subjected to
GAGase incubation lost minimal amounts of GAGs at all time points versus NG stored
controls, revealing retention of inhibitory GAGase activity throughout extended storage
(Figure 24) (p<0.05).

4.3

In-vitro Accelerated Cyclic Fatigue Testing

Evaluation of both crosslinking modalities against in-vitro cyclic fatigue was
conducted to assess stability of GAGs. BHVs underwent 50 millions cycles of fatigue
(~50 days), corresponding to 1.25-1.5 years of in-vivo fatigue in the average adult.
Following fatigue cycling, valves were analyzed for GAG content using hexosamine and
DMMB assays as previously described and were compared with representative nonfatigued stored valves. Hexosamine analysis revealed fatigued NG-crosslinked leaflets
lost a negligible amount of leaflet GAGs when compared to un-fatigued controls (stored),
while fatigued GLUT-crosslinked leaflets lost around 15% (p=0.1425) (Figure 24).

67

Stored
Fatigued

µg GAG s /10mg dry tissue weight

160

Fatigue +
GAGase

120

80

40

0
GLUT

NG

Figure 24: Evaluation of leaflets before and after accelerated cyclic fatigue (50 million
cycles), GAG content analyzed via hexosamine assay. (n=9 per group).
From DMMB analysis, GLUT-fatigued leaflets revealed an ~8 fold increase of
GAGs loss versus NG-fatigued leaflets (Figure 25). NG-crosslinked leaflets exposed to
GAGase incubation after fatigue also exhibited significantly reduced GAG losses when
compared to GLUT leaflets.
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Figure 25: Evaluation of leaflets before and after accelerated cyclic fatigue (50 million
cycles. DMMB of a buffer solution is examined for GAG leaching. (n=9 per group)
Histological evaluation confirmed slightly more intense blue staining in NGfatigued leaflets versus GLUT fatigued valves (Figure 26). These results suggest NGcrosslinked leaflets achieved greater stabilization of GAGs against accelerated in-vitro
fatigue.
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Figure 26:: Histological evaluation of leaflets for GAGs using Alcian Blue. (A,B) GLUTcrosslinked leafletss after fatigue
fatigue; (C,D) NG-crosslinked leaflets afterr fatigue. 100 X
magnification. (n=4)

4.4

Effects of N
NG Crosslinking on Leaflet Hydration

The hydration and rehydration capacity of NG-crosslinked leaflets were
ere measured
As previously described [5].. When compared to GLUT, NG-crosslinked
crosslinked leaflets revealed
significant decreases in hydration and rehydration capacities, showing reductions of
20.7% ± 5.07% and 19.0% ± 4.05%
4.05%, respectively. This is stark in contrast to GLUT
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valves depleted of GAGs, which only resulted in a 12.8% ± 3.9% loss of hydration
capacity. Given that leaflet GAG contents were the same for both NG and GLUTcrosslinked leaflets, hydration capacities of NG-crosslinked leaflets must have been
substantially reduced in a non-GAG related manner (data not shown).

Hydration
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Ratio of wet weight/dry weight

Rehydration
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GLUT + GAGase
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NG+GAGase

Figure 27. NG effects on leaflet hydration versus GLUT and GAG digested samples.
(n=5 per group).
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4.5

Collagen and Elastin Stability

NG-crosslinked
crosslinked leaflets incubated in collagenase revealed a minimal weight loss
percentage of total dry tissue reten
retention versus GLUT-crosslinked leaflets (3.04%± 1.4%
vs. 11.7% ± 1.0% respectively). Similarly, NG-crosslinked leaflets incubated with
elastase lost 17.3% ± 0.9%.of
%.of tissue weight, while GLUT suffered a more substantial loss
of 26.2% ± 1.2%, indicative of increased resistance of NG-crosslinked
crosslinked leaflets to enzyme
mediated degradation of collagen and elastin (Figure 28).
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*
% Weight Loss
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Collagenase

Elastase

lastase-mediated
Figure 28.. Collagen and Elastin stability against (A) Collagenase; (B) Elastase
degradation, represented by % dry tissue weight loss. (n=10 per group, * indicates
significant difference, p<0.05).
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The stability of collagen was analyzed indirectly to ensure that neomycin did not
unfavorably alter glutaraldehyde crosslinking of collagen. Differentially scanning
calorimetry (DSC) was performed to measure collagen denaturation of hydrated leaflets
(Thd). GLUT-crosslinked leaflets exhibited a Thd = 87.69±.47 °C, while NG-crosslinked
leaflets revealed a Thd =89.475 ± .16 °C, as determined using onset temperature of Thd
outlined in (3.2.7.3 Thermal Analysis) (Figure 29). The differences between NG and
GLUT-crosslinked leaflet Thd was found to be statistically significant. Lastly, GLUTcrosslinked leaflet Thd was similar to previously documented results [5,6,42,85].
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Figure 29. NG collagen denaturation, as analyzed using method (1) (n=6 per group, *
indicates significant difference, p<0.05).
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Figure 30. NG effect of collagen denaturation, as analyzed using Thermal Analysis (TA)
via method (2) on dehydrated leaflets. (n=3 per group, * indicates significant difference,
p<0.05).
Further DSC analyses employing freeze-dried (dehydrated) tissues produced results
that were less influenced by water interactions, as variable degrees of hydration
drastically influence collagen denaturation temperatures [115]. Using this method,
denaturation temperature (Tdd) of dehydrated NG and GLUT-crosslinked leaflets were
documented at 208 ± .73 °C and 204.52 ± 1.72 °C using onset points, respectively
(Figure 30). Collectively, results from both methods of analysis suggest that NG does not
unfavorably alter collagen stability, but rather slightly enhances it.
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4.6

Transmission Electron Microscopy of BHVs

The ultra-structural characteristics of collagen-associated GAGs in GLUT and NGcrosslinked leaflets are presented in Figure 31.

Figure 31: TEM ultrastructure of collagen and GAGs in BHVs; (A,B) GLUT leaflets;
(C,D) NG-crosslinked leaflets. 100,000X magnification, 100 kV.
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Toluidine blue effectively stains all GAG types, collapsing the GAG structures to appear
as fine to globular clusters when visualizing with TEM [39]. Collagen fibers, D-banding
and collagen-associated GAGs are clearly visible at intervals consistent with D-banding
(Figure 31). Note the distinction in NG-crosslinked leaflet GAG morphology, which
display larger, more globular and intensely stained GAGs, while GLUT-crosslinked
leaflets reveal more wiry GAG structures. This suggests improved ability of NG to
stabilize leaflet GAGs even during GAG degradative preparations of TEM [39].

4.7
4.7.1

Biomechanics

Biaxial Tensile Results

4.7.1.1 NG versus GLUT-crosslinked leaflets
Biaxial tensile testing was performed and analyzed at high (90 N/m) and low (10
N/m) tensions for studying differences between NG and GLUT-crosslinked leaflets. NGcrosslinked leaflets revealed a decrease in radial stretch but contrastingly increased
circumferential stretches comparative to GLUT-crosslinked leaflets at all tensile stresses.
Low tension analysis in the radial direction revealed significant decrease in radial stretch
(-8.76 %, p=.007) in NG versus GLUT-crosslinked leaflets (Figure 32), indicative of
slightly reduced radial tissue compliancy. However, no significant differences between
NG and GLUT-crosslinked leaflets were encountered between circumferential stretch at
low tensions nor in both circumferential and radial stretch at high tensions (p>.05 for all).
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Figure 32. Biaxial tensile testing of NG and GLUT; (A) High tension analysis; (B) Low
tension analysis.
4.7.1.2 GAG Digested
Biaxial tensile testing was analyzed at high (90 N/m) tensions for studying
differences between NG and GLUT-crosslinked leaflets after GAGase incubation.
Results indicate that GAG digestion in GLUT-crosslinked leaflets results in slight
increases in stretch in both the radial and circumferential direction; however these results
were not statistically significant (Figure 33). NG-crosslinked leaflets exposed to GAGase
similarly experienced a slight increase in radial stretch, but contrastingly exhibited a
decrease in circumferential stretch. Thus, GAG digestion in GLUT valves seems to
slightly increase tissue compliancy, but is not statistically significant using this mode of
analysis (n=12, p>0.05).
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Figure 33. Biaxial tensile testing of (A) NG-crosslinked leaflets before and after
GAGase; (B) GLUT-crosslinked leaflets before and after GAGase (n=12, p>0.05 for all).

4.7.2

Areal Stretch

Further extrapolation of biaxial stretch was used to calculate areal stretch,
yielding a representative expression of tissue compliancy/stiffness (no units) (Figure 34).
Analyses at both low (10 N/m) and high (90 N/m) tensile stress revealed slight decreases
in NG versus GLUT-crosslinked leaflets at both low and high areal stretch, but were not
statistically significant (p>.05).
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Figures 34. Biaxial tensile testing: areal stretch. (n=12, p>0.05 for all)
4.7.3

Hysteresis

GLUT-crosslinked leaflets exhibited ~17.4% hysteresis between loading and
unloading cycles, which is significantly less than that exhibited by fresh tissues (~25%
hysteresis) (Figure 35)

[11]. NG-crosslinked leaflets exhibited slightly increased

hysteresis (17.9%) versus GLUT controls (17.4%), but results were not statistically
significant. Further analysis between GAG-digested groups revealed similar results, with
a slightly higher % hysteresis in NG versus GLUT-crosslinked leaflets, but were lacking
in statistical significance.
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Figure 35. Biaxial tensile testing; areal hysteresis. (n=12, p>0.05 for all)
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CHAPTER 5: DISCUSSION

GAGs play putative mechanical and physiological roles in many tissues including
cartilage, skin, tendons and heart valves [13,29,116]. The relatively large amounts of
GAGs seen in cartilage (up to 30% dry weight) correspond well to the major functional
role of the tissue to resist compressive deformation. In tendons however, GAGs make up
a minimal portion of the ECM (<1%), matching their minimal functional role in these
tissues specialized for tensile resistance [48]. The complicated heart valve function
requires a blend of these functional behaviors, illustrated by the intermediary amount of
GAGs (~3.5% dry weight) within these tissues [7,8,27]. Proteoglycans (PGs), which are
GAGs associated with a protein core, have recently been posited to play a major role in
organizing the collagen matrix, creating “shape modules,” as illustrated by their
orthogonal PG bridges viewed by TEM and computational modeling [37,38,117,118].
This organizational role of GAGs and PGs in association with collagen is insightful of
their additional importance in helping prevent structural collagen damage, as posited in
osteoarthrosis of articular cartilage [38].
Other physiological roles of GAGs include steric protection of collagen from
proteolytic degradation [40]. GAGs have been characterized to mitigate calcification by
prevention of nucleation sites, as highly anionic charges disperse calcium ions [103,119].
Also, digestion by HAase leads to increased tissue permeability and diffusion of blood
elements including ions, enzymes and macrophages [116].
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5.1

Glycosaminoglycan Loss

While further characterization of GAGs in BHV morphological and mechanical
importance have been made [5,9], devitalization of valvular interstitial cells via GLUTcrosslinking precludes remodeling of this essential ECM component. Furthermore,
inability of GLUT to stabilize these structures leads to their inevitable loss in BHVs over
time, adversely affecting valve function [5,7,8]. After 6 months of in-vivo sheep
implantation, GLUT-crosslinked leaflets lost ~90% of valvular GAG content [42].
Correlating this with estimated GAG loss due to in-vitro fatigue and storage at 6 months
(~12% and ~20% respectively), it is reasonable to assume that the most severe mode of
GAG degradation of implanted GLUT-crosslinked BHVs is enzymatic in origin (~60%).
5.2

Previous Work

The severe enzymatic induced GAG loss roused our motivation to bind neomycin,
a potent GAGase inhibitor, to the tissues [23,108,120]. Previous studies involving
EDC/NHS carbodiimide crosslinking of GAGs in conjunction with neomycin have
yielded improved stabilization of GAGs, but compromised valvular compliancy as seen
during uniaxial and biaxial analyses [23,108]. Thus, we hypothesized binding of
neomycin to collagen, without carbodiimide crosslinking of GAGs, would improve GAG
stability while minimally affecting valvular compliancy.
5.3

Resistance to GAG degrading enzymes

Confirmed by numerous analyses, NG-crosslinked leaflets exhibited resistance to
the most potent GAG loss mode: GAGases degradation. To confirm neomycin was
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responsible

for

the

increased

enzymatic

resistance,

a

neomycin

analog,

deoxystreptamycin, was previously employed and indeed revealed significant amounts of
loss during GAGase incubation [108]. The chondroitinase and hyaluronidase enzymes
that constitute the GAGase cocktail have similar mechanism in degrading GAGs by
cleaving 1,4 β and1,3 β-glycosidic bonds, respectively [116, 121]. The similar cleavage
mechanism is further highlighted by the ability of the singular neomycin molecule to
block both types of enzymes. Neomycin is thought to confer GAGases inactive by
binding to them and inducing conformational changes that render them non-functional
[9]. However, whether or not neomycin is permanently attached or degraded in the
process has not been characterized and holds important implications for the long-term
efficacy of GAGase resistance offered by NG crosslinking.
5.4

Stability of GAGs against Storage and Fatigue

Clinically, valves may be subjected to storage for up to 36 months [122].
Significant GAG losses have been documented in storage, approaching ~30% after only 6
months in GLUT-crosslinked leaflets [6]. NG-crosslinked leaflets revealed retention of
inhibitory GAGase activity in over time, indicating stable incorporation of active
neomycin into the BHVs (Figure 23), and is significant as enzymatic GAG degradation
is the most severe form of GAG loss.
NG-crosslinked leaflets retained significantly greater amounts of GAGs relative to
GLUT-crosslinked leaflets at all time points during storage, ~25% of GAG loss after 1
year versus 55% respectively. However, it is clear that NG-crosslinked leaflets still
displayed a considerable rate of GAG loss. Thus, absence of carbodiimide GAG
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crosslinking precludes NG-crosslinked leaflets to some GAG loss in storage, but not as
rapid as GLUT-crosslinked leaflets [5]. This enhanced GAG stability is probably due to
enhanced crosslinking action by GLUT in conjunction with neomycin that makes it more
difficult for GAG chains to dissociate and leach out into solution. However, it is also
possible that there are still active GAGases in the GLUT-crosslinked leaflets during
storage and that neomycin is actively inhibiting their degradative effects [7,8].
BHVs subjected to 50 million cycles of fatigue, or the equivalent of ~1.5 years in
the average adult, were compared to un-cycled leaflets in storage to individually assess
fatigue-induced GAG loss. Relative to stored controls, GLUT-crosslinked leaflets
revealed ~15% decrease in leaflet GAGs (p=.1425, n=9). While not statistically
convincing, it is important to consider that GLUT-crosslinked leaflets in fatigue lose
GAGs both due to storage (50 days of cycling) and fatigue, concomitantly. Thus, when
compared to un-fatigued, un-stored controls, GLUT-fatigued leaflets lost ~20% of leaflet
GAGs, which is statistically significant (p<.0.05). Comparatively, NG-crosslinked
leaflets were significantly more resistant to fatigue induced GAG loss, as no statistical
differences were found in NG-fatigued leaflets compared to stored and un-stored controls
(p>0.05).

5.5

Decreased Water Content

Reduced hydration in leaflet tissues have been shown to alter internal shearing [28],
lead to morphological changes [5] and increased buckling in BHVs [9] , adversely
affecting proper biomechanical function. Two culprits for this decreased leaflet hydration
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include GAG loss and chemical crosslinking, which have been characterized previously
in our lab and others [5,28,90]. NG crosslinking led to a substantial decrease in hydration
capacity, more so than that exhibited by GLUT-crosslinked leaflets removed of GAGs.
This was probably due to enhanced crosslinking, which is indirectly proportional to the
hydration capacity. It may be that decreased hydration contributes to increased enzymatic
resistance of tissues, as enzymatic diffusion and activity in a less aqueous (more solid)
environment are reduced [123].
5.6

Enzymatic Collagen and Elastin Stability

Previous literature have suggested that functional preservation and protection of
collagen is the most important aspect of BHV durability, as it is the deterioration and
failure of these fibers that lead to valvular dysfunction, patient morbidity and mortality
[1,13]. Initial deterioration of GAGs and elastin may enhance collagen damages,
justifying their importance and preservation in BHVs, but it is the structural stability of
collagen that requires stern scrutiny.
Thus, we examined NG-crosslinked leaflets for collagen and elastin stability, to
ensure that other ECM components were not compromised in the process of NG
crosslinking. NG-crosslinked leaflets interestingly revealed a significantly improved
resistance to collagenase and elastase degradation. This provides support for important
implications including the enhanced crosslinking imposed by NG crosslinking. Chueng
previously described resistance of GLUT-crosslinked collagen to enzymatic degradation
as a quantitative analysis for this otherwise difficult parameter to observe [124].
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Furthermore, increased elastase resistance reveals additional support for the increased
crosslinking density in NG-crosslinked leaflets.
Overall, all three major ECM components are more resistant to enzymatic loss in
NG than GLUT-crosslinked leaflets, confirming that enhanced crosslinking must indeed
provide steric hindrance to diffusion and access of these enzymes to their targeted
substrates. Furthermore, decreased hydration as a consequence of additional crosslinking
may contribute to increased enzymatic resistance as well.
5.7

Enhanced Collagen Td

Further evaluation of collagen stability was observed by identifying collagen
denaturation in both hydrated (Thd)and dehydrated (Td) samples using DSC. Collagen Td
relates to transition of collagen from native triple helical structure into a more random
coiled structure due to heating [112-114,125] While highly debated as to which is most
significant, inter-helical hydrogen bonding, water molecular bridging, hydrophobic
interactions and inductive effects of hydroxyproline are all posited stabilizing
mechanisms of the collagen helix [41,112,114]. Heating the tissues must sever these
molecular stabilizations and it has been shown that GLUT-crosslinking increases the
temperature at which this occurs in tissues, from ~60oC to ~90oC [112,125]. While the
underlying mechanism at the molecular level for which GLUT provides this increase are
still largely unknown, they are thought to involve loss of chain entropy because of
increased covalently linked molecules and dehydration [125].
NG-crosslinked leaflets subjected to DSC revealed a small, but significant increase
in collagen Td, utilizing both hydrated and dehydrated samples (p=0.017,p=0.053
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respectively). Hydrated samples were run to see if the changes in hydration capacity
induced during NG crosslinking caused an observable change in collagen Thd.
Dehydrated samples were employed to observe collagen Td without the effects of
hydration, which are documented to strongly influence collagen [112,113,115,125].
Hydrated samples revealed an average 2.0% increase in collagen Td while dehydrated
samples yielded a 1.76% increase in both modes of analysis (p=0.024, p=0.034).
Previously, Miles reported a ~10 degrees increase of collagen Td in rat tail during 20%
decreased hydration [125].

Correlating the similarly decreased hydration capacity

(20.7%) of NG-crosslinked leaflets to minimally increased collagen Thd suggests that the
mechanism of decreased hydration in NG-crosslinked leaflets is not strongly affecting the
actual collagen hydration [125]. Rather, decreased hydration may be a consequence of
increased crosslinking that decreases ECM spacing, squeezing out bulk water from the
tissue spaces peripheral to the intra and inter-fibril spaces. This is further supported by
the NG-crosslinked leaflets that were dehydrated which still maintained a significantly
increased collagen Td reaffirming that decreased hydration was not a significant factor in
increasing collagen Td.
GLUT itself can form large, complex crosslinking bridges, exemplified during high
concentration of GLUT in aqueous solutions which can be so dense that they prevent
further penetration of GLUT to fix tissues deep to the surfaces [76,90,92]. Thus, it seems
GLUT can accommodate a variety of larger crosslinking distances, especially at higher
concentrations, but perhaps only a limited number of smaller crosslinking distances.

87

The locations of GLUT-crosslinks in collagen are complex and generally occur at
all trophic levels of collagen organization but at relatively different concentrations. Intrahelical cross-links require precise appositional cross-linkable distances between moieties
on the same helix which are relatively infrequent (1/100aa’s have appropriate amine
moieties) and may entail sterically restrictive GLUT-collagen interaction [91,92] .
Crosslinking at the inter-helical and inter-fibril level, when appositional spacing is close
enough, are thought to be the main mechanism of collagen crosslinking via GLUT
[90,95]. Ultra-structural analysis using atomic force microscopy has recognized the
altered collagen fibril structure after GLUT-crosslinking, showing disrupted and
decreased D-banding patterns, confirming crosslinking at inter and possibly intra-helical
locations [96,97]. Collectively, it is likely that larger neomycin-GLUT-complexes
enhance inter-helical, inter-fibril and inter-fiber crosslinking densities within BHVs
[73,88,89,90].
The increased collagen Td of NG-crosslinked leaflets, while being significant, was
still relatively small probably because the enhanced GLUT-crosslinking that occurred did
not largely affect the stability of triple helix. This is logical, as larger neomycin-GLUT
complexes would favor larger inter-helical, fibril and fiber cross-links. Furthermore, it
could also be that these short intra-helical distances are cross-linked by GLUT at low
concentrations, that is, the most possible intra-helical cross-links are already met by
GLUT alone.
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From the data however, we can only support the hypothesis that NG is not
significantly increasing intra-helical bonding stability of collagen molecules, nor
enhancing GLUT-crosslinking at other trophic levels.
5.8

Transmission Electron Microscopy

Qualitative analysis of NG-crosslinked leaflets with TEM reveal significant
retention of collagen associated GAGs in enzymatically degraded samples. Furthermore,
staining of GAGs are much more intense than GLUT controls, which exhibit a much
more thin and wiry morphology. This thin wiry structure is most likely the leftovers of
the protein core of the collagen associated proteoglycans (decorin, biglycan) [8,39],
suggesting associated GAGs are lost even in GLUT controls. NG-crosslinked leaflets
offer interesting morphological preservation of GAGs that have not been seen in the
literature using toluidine blue, probably because of the additional stabilization of these
delicate ECM structures. Thus, keeping those collagen-associated GAG structures with
neomycin binding may increase fatigue resistance of collagen, thus improving the
durability of the BHV.
5.9

Biomechanics

NG-crosslinked leaflets and GLUT-crosslinked leaflets showed no statistical
differences between circumferential and radial areal stretch. However, further refinement
revealed NG-crosslinked leaflets did exhibit a small but statistically significant decrease
in radial stretch at low tensions. Conversely, NG did not reveal a significant change in
circumferential stiffness during both low and high tension analyses. Collectively, these
two results indicate that enhanced NG crosslinking may be responsible, as additional
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bridges formed in the radial direction between the circumferentially oriented collagen
structures inhibit their radial extensibility.
GLUT-crosslinked leaflets removed of GAGs revealed a small increase in radial
and circumferential stretch, indicative of an increase in tissue compliancy. While these
results were insignificant, further evaluation and statistical confirmation may reveal an
additional role of GAGs in providing lateral force transfer between collagen fibers as
exhibited in cartilage [117]. As, GAGs and PGs were also posited in organizing collagen
fibers and maintaining appropriate fiber-fiber interactions during function [37,38,40].
Thus, an increase in areal compliancy may be indicative of the loss of this ECM function
and further posits important implications for GAG and PG preservation. NG-crosslinked
leaflets exposed to GAGase incubation did not reveal any significant differences in tissue
mechanics and further confirm the resistance of NG-crosslinked leaflets to GAGase
degradation.
Further extrapolation of biaxial data revealed a slight increase in hysteresis in
NG-crosslinked leaflets versus GLUT, indicative of additional energy dissipation that
may be occurring due to GAG retention. Furthermore, GAG digested GLUT-crosslinked
leaflets experienced a small decrease in hysteresis and is indicative of decreased
hydration as a consequence of GAG loss. However, these results were not statistically
significant, most likely due to the insensitivity of biaxial analyses to the small tensile
influences GAGs. Furthermore, the increased % hysteresis in NG-crosslinked leaflets,
while potentially beneficial, was also statistically insignificant. Thus, it is necessary that
more sensitive modes of analysis be used to infer the delicate biomechanical alterations
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of GAG loss and enhanced crosslinking. While these changes in biomechanical behavior
may seem minimal and insignificant, it is important not to undermine them as the heart
valve relies on near-perfect biomechanical behaviors to sustain its structural integrity
over billions of cycles.
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6

CHAPTER 6
CONCLUSIONS AND RECOMMENDATIONS
6.1

Conclusions

It is disheartening to note that despite the numerous advances in design of BHVs
over the last 4 decades, none have come close to the innovations made early on in the
1960’s when chemical treatment of tissue-based valves was changed from formaldehyde
to the far superior GLUT. The limited durability of GLUT-crosslinked leaflets is a
serious issue for the millions of individuals who currently posses a BHV. Thus, it is vital
that this device is further improved to meet the demanding role of withstanding 40
million cycles per year for the remainder of the patient’s life.
Current GLUT-crosslinking fails to stabilize critical extracellular matrix
components, particularly GAGs. These hydrophilic, unbranched mucopolysaccharides are
heavily laden throughout the native and cross-linked bioprosthetic heart valve
architecture in all three layers and command numerous roles that facilitate proper heart
valve function. From providing a hydrated milieu that maintains proper leaflet
morphology, lubrication and collagen organization, to biomechanical roles that including
shear stress modulation and absorption of compressive loads, valvular GAGs are critical
to the durability of native heart valves. However, enzymatic GAG degradation and GAG
diffusion during storage and fatigue deplete BHVs of this ECM component over time.
Thus, proper biomechanical function of BHVs is compromised, adversely affecting
collagen which must undergo shearing, compression, bending and flexure without the
organizational, hydrating and stress mitigating assistance of GAGs.
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From our studies it is clear that GLUT-crosslinking is insufficient in preserving
GAGs from a variety of mechanisms. Incorporating neomycin, a known GAGase
inhibitor, into the tissues was collectively shown to attenuate GAG loss during: (a)
storage (b) fatigue and (c) GAGase incubation. NG crosslinking was shown to (a) slightly
increase collagen denaturation (b) improve collagen and elastin stability against
enzymatic degradation and (c) decrease hydration capacity of the leaflets. Biomechanical
analysis using biaxial tensile testing revealed similar (a) compliancy between GLUT and
NG-crosslinked leaflets and (b) hysteretic behavior.
Thus, we have shown that neomycin enhances GLUT-crosslinking and stabilizes
GAGs in way that does is not significantly detrimental to the biomechanical compliancy
of the BHVs. Furthermore, the NG treatment may be beneficial to attenuating other postimplant reactions due to additional immunogenic masking as a byproduct of increased
crosslinking density. Thus, NG treatment may attenuate the structural degradation and
failure rates of BHVs from a variety of mechanisms that render current BHVs far from
ideal.
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6.2

Recommendations

Critical insight into the functional role of GAGs is not only important in BHVs,
but other tissue-based prosthetics, scaffolds and fully engineered tissue organs that are at
the cusp of bioengineering. Thus, characterization of GAG biomechanics are warranted,
specifically in attention to dynamic mechanical function, associated collagen stabilization
and reinforcement and for purposes related to tissue engineering.
Characterization of GAGs in BHVs could be analyzed using differential scanning
calorimetry before and after GAGase exposure. Furthermore, NG treatment could be
correlated with thermogravic analysis to assess water bound departure and relation of
hydration to collagen denaturation temperature, as the documented decrease in hydration
may account for increase in the temperature of collagen denaturation.
Neomycin crosslinking should be further coupled with anti-calcification
treatments to further prevent other mechanisms of BHV failure. Long-term sub-dermal
implantations need to assess efficacy of NG treatment over time, as GAGs were clearly
diminished during storage. Further analysis in immunogenic masking as a byproduct of
additional crosslinking densities may be beneficial in attenuating the inflammatory
reaction.
Analysis of regional GAG contents in layers and in zones are important for
purpose of tissue engineering heart valves and correlating GAG to regional functional
roles, whether it is based on spatial location (i.e. middle spongiosa, fibrosa) or with
certain structures (elastin or collagen or even cells).
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